Form D · Biotechnology
THERALINK TECHNOLOGIES, INC.
Golden, CO · CIK 0001362703
Offering snapshot reported Dec 14, 2022 · SEC filing
- Reported sold
- $0 Offering amount: $3.4M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $100K Reported outside-investor minimum
- First sale
- Nov 29, 2022 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Dec 14, 2022 | Initial | $0 | No comparison | 12 | SEC filing |
| Feb 12, 2021 | Initial | $400,000 | No comparison | 4 | SEC filing |
| May 29, 2019 | Initial | $184,950 | No comparison | 36 | SEC filing |
| Oct 9, 2018 | Initial | $1,225,000 | No comparison | 4 | SEC filing |
| Dec 30, 2015 | Initial | $95,000 | No comparison | 1 | SEC filing |
| Oct 13, 2015 | Initial | $515,700 | No comparison | 38 | SEC filing |
| Jul 9, 2010 | Initial | $175,000 | No comparison | 2 | SEC filing |
| Jun 15, 2010 | Initial | $10,000 | No comparison | 1 | SEC filing |
| May 5, 2006 | Paper | Not reported | No comparison | Not reported |
Offering details
- Securities
- Debt, Option to acquire
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $300K (estimated)
- Finders' fees
- $0
- Form D file number
- 021-467468
Sales compensation recipients
Scroll to see all columns →
| Recipient | CRD | Associated broker-dealer |
|---|---|---|
| Joseph Gunnar & Co. LLC | 24795 |
Source: Form D, filed Dec 14, 2022. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brian Barnett, M.D. | Executive |
| Jeffrey Busch | Director |
| Joseph Carusone | Director, Executive |
| Thomas Chilcott | Executive |
| Thomas Chilcott, Iii | Executive |
| Robert L. Elliott | Director |
| Robert Elliott, Jr. | Director, Executive |
| Yvonne Fors | Director |
| Jonathan F. Head | Director, Executive |
| Jonathan F. Head, Ph.D | Director |
| Robert N Holcomb | Director |
| Danica Holley | Director |
| Daniel S Hoverman | Director |
| Andrew Kucharchuk | Director |
| Charles L. Rice | Director |
| Charles L Rice, Jr | Director |
| Charles L. Rice, Jr. | Director |
| Mick Ruxin | Director, Executive |
| Mick Ruxin, Md | Director, Executive |
| Matthew W. Schwartz, Md | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
15000 W. 6 Th Ave., #400
Golden, CO, 80401
Golden, CO, 80401